A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium

R. Nasreddine, E. Florence, J. Yombi, S. Henrard, G. Darcis, J. Van Praet, L. Vandekerckhove, S. Allard, R. Demeester, P. Messiaen, N. Ausselet, M. Delforge, S. De Wit

Research output: Contribution to journalConference abstract in journalpeer-review

Original languageEnglish
JournalJournal of the International AIDS Society
Pages (from-to)116-117
Number of pages2
Publication statusPublished - 2022

Cite this